Growth inhibition of experimental pancreatic cancers and sustained reduction in epidermal growth factor receptors during therapy with hormonal peptide analogs

Journal of Cancer Research and Clinical Oncology

Volumn 125, Issue 8-9, 1999, Pages 444-452

  Szepesházi, Karoly ^a,b   Halmos, Gabor ^a,b   Schally, Andrew V ^a,b   Arencibia, José M ^b   Groot, Kate ^a   Vadillo Buenfil, Manuel ^b   Rodriguez Martin, Eulalia ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

AgNOR; Apoptosis; Bombesin antagonist; EGF receptor; Experimental pancreatic cancer; Hormonal therapy; LH RH antagonist; Somatostatin analog

Indexed keywords

BOMBESIN ANTAGONIST; CETRORELIX; EPIDERMAL GROWTH FACTOR RECEPTOR; GASTRIN RELEASING PEPTIDE; GONADORELIN ANTAGONIST; HORMONE ANALOG; NITROSAMINE; RC 3095; SOMATOSTATIN DERIVATIVE; VAPREOTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BINDING AFFINITY; CANCER HORMONE THERAPY; CANCER INHIBITION; CONTROLLED STUDY; DRUG INDUCED DISEASE; EXPERIMENTAL NEOPLASM; FEMALE; HAMSTER; NONHUMAN; PANCREAS CANCER; PANCREAS TUMOR; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION;

ANIMALS; ANTINEOPLASTIC AGENTS, HORMONAL; APOPTOSIS; BOMBESIN; CRICETINAE; DISEASE MODELS, ANIMAL; DOWN-REGULATION; ESTRADIOL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GONADOTROPIN-RELEASING HORMONE; GROWTH HORMONE; LUTEINIZING HORMONE; MESOCRICETUS; MITOTIC INDEX; NUCLEOLUS ORGANIZER REGION; PANCREATIC NEOPLASMS; PEPTIDE FRAGMENTS; RECEPTOR, EPIDERMAL GROWTH FACTOR; TIME FACTORS;

EID: 0032821184     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004320050301     Document Type: Article

References (38)

1. Avis I, Jett M, Kasprzyk PG, Cuttitta F, Treston AM, Maneckjee R, Mulshine JL (1993) Effect of gastrin-releasing peptide on the pancreatic tumor cell line (Capan). Mol Carcinog 8:214-220
2. Bell GI, Reisine T (1993) Molecular biology of somatostatin receptors. Trends Neurosci 16:34-38
3. Breier BH, Gallaher BW, Gluckman PD (1991) Radioimmunoassay for insulin-like growth factor-I: solutions to some potential problems and pitfalls. J Endocrinol 128:347-357
4. Bunnett N (1994) Gastrin-releasing peptide. In: Walsh JH, Dockray GJ (eds) Gut peptides: biochemistry and physiology. Raven, New York
5. Carpenter G, Cohen S (1990) Epidermal growth factor. J Biol Chem 265:7709-7712
6. Derenzini M, Trere D (1991) Importance of interphase nucleolar organizer regions in tumor pathology. Virchows Arch [B] 61:1-8
7. Douglas BR, Woutersen RA, Jansen JBM, DeJong AJL, Rovati LC, Lamers CBHW (1989) Influence of cholecystokinin antagonist on the effects of cholecystokinin and bombesin on azaserine induced lesions on rat pancreas. Gastroenterology 96:462-469
8. 6]-luteinizing hormone-releasing hormone in experimental pancreatic cancer. Cancer Lett 45:87-91
9. Halmos G, Schally AV (1997) Reduction in receptors for bombesin and epidermal growth factor in xenografts of human small-cell lung cancer after treatment with bombesin antagonist RC-3095. Proc Natl Acad Sci USA 94:956-960
10. Halmos G, Schally AV, Pinski J, Vadillo-Buenfil M, Groot K (1996) Down-regulation of pituitary receptors for luteinizing hormone-releasing hormone (LH-RH) in rats by LH-RH antagonist Cetrorelix. Proc Natl Acad Sci USA 93:2398-2402
11. Korc M, Meltzer P, Trent J (1986) Enhanced expression of epidermal growth factor receptor correlates with alterations of chromosome 7 in human pancreatic cancer. Proc Natl Acad Sci USA 83:5141-5144
12. Lee MT, Liebow C, Kamer AR, Schally AV (1991) Effects of epidermal growth factor and analogs of luteinizing hormone-releasing hormone and somatostatin on phosphorylation and dephosphorylation of tyrosine residues of specific protein substrates in various tumors. Proc Natl Acad Sci USA 88:1656-1660
13. Liebow C, Reilly C, Serrano M, Schally AV (1989) Somatostatin analogs inhibit growth of pancreatic cancer by stimulating tyrosine phosphatase. Proc Natl Acad Sci USA 86:2003-2007
14. Liebow C, Crean DH, Lee MT, Kamer AR, Mang TS, Schally AV (1994) Synergistic effects of bombesin and epidermal growth factor on cancers. Proc Natl Acad Sci USA 91:3804-3808
15. Longnecker DS (1991) Hormones and pancreatic cancer. Int J Pancreatol 9:81-86
16. Millar JBA and Rozengurt E (1990) Chronic desensitization to bombesin by progressive down-regulation of bombesin receptors in Swiss 3T3 cells. J Biol Chem 265:12 052-12 058
17. 2+ and protein kinase C. Eur J Endocrinol 136:123-127
18. O'Byrne KJ, Halmos G, Pinski J, Groot K, Szepeshazi K, Schally AV, Carney DN (1994) Somatostatin receptor expression in lung cancer. Eur J Cancer 30A:1682-1687
19. Perilli D, Mansi C, Savanno V, Celle G (1993) Hormonal therapy of pancreatic carcinoma. Int J Pancreatol 13:159-168
20. Poston GJ, Gillespie J, Guillou PJ (1991) The biology of pancreatic cancer. Gut 32:800-812
21. Pour P, Mohr U, Cardesa A, Althoff J, Kruger FW (1975) Pancreatic neoplasms in an animal model: Morphological, biological, and comparative studies. Cancer 36:379-389
22. Schally AV (1994) Hypothalamic hormones: from neuroendocrinology to cancer therapy. Anticancer Drugs 5:115-130
23. Schally AV, Comaru-Schally AM (1997) Hypothalamic and other peptide hormones. In: Holland JF, Frei E III, Bast RC Jr, Kufe DE, Morton DL, Weichselbaum RR (eds) cancer medicine. Williams & Wilkins, Baltimore, Md, pp 1067-1086
24. Schally AV, Szepeshazi K, Qin Y, Halmos G, Ertl T, Groot K, Cai R-Z, Liebow C, Poston GJ (1994) Antitumor effects of analogs of somatostatin and antagonists of bombesin/GRP in experimental models of pancreatic cancer. Int J Pancreatol 16:246-249
25. Szende B, Srkalovic G, Groot K, Lapis K, Schally AV (1990a) Regression of nitrosamine-induced pancreatic cancers in hamsters treated with luteinizing hormone-releasing hormone antagonists or agonists. Cancer Res 50:3716-3721
26. Szende B, Srkalovic G, Schally AV, Lapis K, Groot K (1990b) Inhibitory effects of analogs of luteinizing hormone-releasing hormone and somatostatin on pancreatic cancers in hamsters. Cancer 65:2279-2290
27. Szepeshazi, K, Lapis K, Schally AV (1991a) Effect of combination treatment with analogs of luteinizing hormone-releasing hormone (LH-RH) or somatostatin and 5-fluorouracil on pancreatic cancer in hamsters. Int J Cancer 49:260-266
28. Szepeshazi K, Schally AV, Cai R-Z, Radulovic S, Milovanovic S, Szoke B (1991b) Inhibitory effect of bombesin/gastrin-releasing peptide antagonist RC-3095 and high dose of somatostatin analog RC-160 on nitrosamine-induced pancreatic cancers in hamsters. Cancer Res 51:5980-5986
29. Szepeshazi K, Schally AV, Halmos G, Groot K, Radulovic S (1992) Growth inhibition of estrogen-dependent and estrogen-independent MXT mammary cancers in mice by the bombesin and gastrin-releasing peptide antagonist RC-3095. J Natl Cancer Inst 84:1915-1922
30. Szepeshazi K, Schally AV, Groot K, Halmos G (1993) Effect of bombesin, gastrin-releasing peptide (GRP) (14-27) and bombesin/GRP receptor antagonist RC-3095 on growth of nitrosamine-induced pancreatic cancers in hamsters. Int J Cancer 54:282-289
31. Szepeshazi K, Halmos G, Groot K, Schally AV (1994) Combination treatment of nitrosamine-induced pancreatic cancers in hamsters with analogs of LH-RH and a bombesin/GRP antagonist. Int J Pancreatol 16:141-149
32. Szepeshazi K, Schally AV, Cai R-Z, Halmos G, Groot K (1996) Effects of new bombesin antagonists given singly or in combination with a somatostatin analog on nitrosamine-induced pancreatic cancers in hamsters. Int J Oncol 9:397-403
33. Szepeshazi K, Schally AV, Halmos G, Lamharzi N, Groot K, Horvath JE (1997) A single in vivo administration of BN antagonist RC-3095 reduces the levels and mRNA expression of epidermal growth factor receptors in MXT mouse mammary cancers. Proc Natl Acad Sci USA 94:10 913-10 918
34. Takiyama Y, Egami H, Pour PM (1990) Expression of human tumor-associated antigens in pancreatic cancer induced in Syrian hamsters. Am J Pathol 136:707-715
35. Tallet A, Chilvers ER, MacKinnon AC, Haslett C, Sethi T (1996) Neuropeptides stimulate tyrosine phosphorylation and tyrosine kinase activity in small cell lung cancer cell lines. Peptides 17:665-673
36. Thomas F, Mormont C, Morgan B (1994) Gastrin-releasing peptide antagonists. Drugs Future 19:349-359
37. Wang QJ, Knezetic JA, Schally AV, Puor PM, Adrian TE (1996) Bombesin may stimulate proliferation of human pancreatic cancer cells through an autocrine pathway. Int J Cancer 68:528-534
38. Zachary I, Sinnett-Smith JW, Rozengurt E (1986) Early events elicited by bombesin and structurally related peptides in quiescent Swiss 3T3 cells. I. Activation of protein kinase C and inhibition of epidermal growth factor binding. J Cell Biol 102:2211-2222